Gavin Arno, PhD, of the Greenwood Genetic Center, has received a 300,000 dollar research grant from the Foundation Fighting Blindness. This funding supports a three-year project dedicated to identifying the genetic drivers of inherited retinal diseases. These conditions damage the retina and lead to vision loss, yet many patients currently lack a definitive diagnosis.
Dr. Arno intends to use long-read DNA sequencing to locate genetic changes that remain undetected by standard testing procedures. By uncovering these hidden factors, the research team aims to provide clearer answers for families who have searched for years to understand their condition. This clarity is a necessary step for patients to qualify for emerging gene-based therapies.
The project builds upon previous work supported by the National Institutes of Health. It seeks to close the existing diagnostic gap, which prevents many of the 5.5 million people affected by these diseases globally from receiving appropriate medical care. By mapping these genetic variants, the team hopes to expand access to precision medicine and specialized treatments.
Dr. Steve Skinner, CEO of the Greenwood Genetic Center, stated that the work combines advanced genomic technology with a commitment to patient outcomes. As gene-based medical options continue to arrive in clinical settings, accurate identification of underlying causes remains a priority for the research community.